| Effect of Liraglutide on Heart Frequency in Healthy Volunteers (NCT01516255) | Novo Nordisk A/S | 2006-07-01 |
| Insulin Glulisine in Type 2 Diabetic Patients (NCT00360698) | Sanofi | 2006-07-01 |
| Left Ventricular DYsfunction in DiAbetes (NCT01971125) | Heart Care Foundation | 2006-07-01 |
| A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients (NCT00336310) | National Cheng-Kung University Hospital | 2006-07-01 |
| A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes. (NCT00366379) | Hoffmann-La Roche | 2006-07-01 |
| Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands (NCT01536626) | Novo Nordisk A/S | 2006-06-09 |
| Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers (NCT01538511) | Novo Nordisk A/S | 2006-06-05 |
| A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes (NCT00351832) | Novartis | 2006-06-01 |
| Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005) (NCT00543959) | Merck Sharp & Dohme LLC | 2006-06-01 |
| Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients (NCT00859079) | Medical University of Graz | 2006-06-01 |
| Comparison of NovoFine® Needles (4 mm vs. 6 mm) (NCT00343343) | Novo Nordisk A/S | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers (NCT01489644) | Novo Nordisk A/S | 2006-06-01 |
| Insulin Glargine in Type 2 Diabetic Patients (NCT00347100) | Sanofi | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers (NCT01490658) | Novo Nordisk A/S | 2006-06-01 |
| A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes (NCT00330473) | Eli Lilly and Company | 2006-06-01 |
| Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients (NCT00337038) | Soroka University Medical Center | 2006-06-01 |
| Exercise Training in Older Diabetic Women (NCT00341614) | University of San Francisco | 2006-06-01 |
| Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma (NCT00332826) | Mannkind Corporation | 2006-06-01 |
| A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study (NCT00432679) | GlaxoSmithKline | 2006-05-24 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00333151) | Novo Nordisk A/S | 2006-05-01 |
| Insulin Glargine "All to Target" Trial (NCT00384085) | Sanofi | 2006-05-01 |
| Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes (NCT01545791) | Novo Nordisk A/S | 2006-05-01 |
| RCT of the Naturopathic Anti-Inflammatory Diet (NCT00334919) | National University of Natural Medicine | 2006-05-01 |
| Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes (NCT00351884) | Novartis Pharmaceuticals | 2006-05-01 |
| The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes (NCT00321321) | University Hospital, Gentofte, Copenhagen | 2006-05-01 |
| Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes (NCT00822367) | Walter Reed Army Medical Center | 2006-05-01 |
| Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients (NCT00328172) | Boehringer Ingelheim | 2006-05-01 |
| Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study (NCT00325910) | University of Alberta | 2006-05-01 |
| The Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases (NCT00300976) | Japan Foundation for the Promotion of International Medical Research Cooperation | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00331851) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00318422) | Novo Nordisk A/S | 2006-05-01 |
| To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together (NCT00318461) | Novo Nordisk A/S | 2006-05-01 |
| Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes (NCT00309608) | Boehringer Ingelheim | 2006-04-01 |
| To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy (NCT00325117) | Novartis | 2006-04-01 |
| Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. (NCT00313001) | Novo Nordisk A/S | 2006-04-01 |
| Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes (NCT00318786) | Novo Nordisk A/S | 2006-04-01 |
| Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes (NCT00325364) | Eli Lilly and Company | 2006-04-01 |
| Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes (NCT00325429) | Novartis | 2006-04-01 |
| GW823093C For The Treatment Of Type 2 Diabetes Mellitus (NCT00370942) | GlaxoSmithKline | 2006-04-01 |
| Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus (NCT00372957) | GlaxoSmithKline | 2006-03-22 |
| A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus (NCT00282971) | Pfizer | 2006-03-06 |
| LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus (NCT00423215) | Sanofi | 2006-03-01 |
| Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes (NCT00233259) | Oregon Research Institute | 2006-03-01 |
| A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone (NCT00295633) | AstraZeneca | 2006-03-01 |
| Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients (NCT00465478) | Shandong University | 2006-03-01 |
| Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function (NCT01507389) | Novo Nordisk A/S | 2006-03-01 |
| An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus (NCT01542424) | Novo Nordisk A/S | 2006-03-01 |
| Physical Activity and Mortality in Type 2 Diabetes (NCT05380232) | Aarhus University Hospital | 2006-03-01 |
| Renal Impairment in Type 2 Diabetic Subjects (NCT00554450) | AstraZeneca | 2006-03-01 |
| A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia (NCT00300287) | Novartis | 2006-02-20 |
| Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin (NCT00287807) | Medical Research Foundation, The Netherlands | 2006-02-01 |
| Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (NCT00351676) | University of Alberta | 2006-02-01 |
| Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment (NCT01548235) | Novo Nordisk A/S | 2006-02-01 |
| Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control (NCT00283049) | Sanofi | 2006-02-01 |
| To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c (NCT00294723) | Novo Nordisk A/S | 2006-02-01 |
| A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. (NCT00316758) | Hoffmann-La Roche | 2006-02-01 |
| Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes (NCT00282451) | Novo Nordisk A/S | 2006-02-01 |
| Internet Diabetes Self-Management Workshop (NCT00185601) | Stanford University | 2006-02-01 |
| In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus (NCT00354536) | GlaxoSmithKline | 2006-02-01 |
| BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy- (NCT00297063) | GlaxoSmithKline | 2006-01-11 |
| Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes (NCT01536639) | Novo Nordisk A/S | 2006-01-01 |
| Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917 (NCT00290940) | Daiichi Sankyo | 2006-01-01 |
| Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion (NCT00566358) | University of Campinas, Brazil | 2006-01-01 |
| Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers (NCT01515592) | Novo Nordisk A/S | 2006-01-01 |
| A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes. (NCT00368368) | Hoffmann-La Roche | 2006-01-01 |
| GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients (NCT00291356) | GlaxoSmithKline | 2006-01-01 |
| Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes (NCT00380445) | Novartis | 2006-01-01 |
| Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes (NCT01486875) | Novo Nordisk A/S | 2006-01-01 |
| A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes. (NCT00380380) | Novartis | 2006-01-01 |
| Understanding and Improving Diabetes Care for Ethnic Minorities (NCT01123239) | University of California, Irvine | 2006-01-01 |
| Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes (NCT01536652) | Novo Nordisk A/S | 2006-01-01 |
| Omentectomy for the Treatment of Diabetes Mellitus Type 2 (NCT00270439) | Vanderbilt University | 2006-01-01 |
| Efficacy and Safety of Levemir® Used as Basal Insulin (NCT01548248) | Novo Nordisk A/S | 2006-01-01 |
| Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction (NCT00300911) | Baskent University | 2005-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec (NCT01865279) | Novo Nordisk A/S | 2005-12-01 |
| The Use of Cilostazol in Patients With Diabetic Nephropathy (NCT00272831) | Chinese University of Hong Kong | 2005-12-01 |
| The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) (NCT00279201) | Eli Lilly and Company | 2005-12-01 |
| Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes (NCT00267683) | Novo Nordisk A/S | 2005-12-01 |
| A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (NCT00523913) | GlaxoSmithKline | 2005-11-01 |
| A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes (NCT00260156) | Novartis Pharmaceuticals | 2005-11-01 |
| Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes (NCT01511692) | Novo Nordisk A/S | 2005-11-01 |
| A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin (NCT00266253) | Hoffmann-La Roche | 2005-11-01 |
| A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus (NCT00266240) | Hoffmann-La Roche | 2005-11-01 |
| US Inhaled Insulin Dose Titration Study (NCT00246623) | Pfizer | 2005-11-01 |
| Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs (NCT01486862) | Novo Nordisk A/S | 2005-10-01 |
| A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients (NCT00349427) | GlaxoSmithKline | 2005-10-01 |
| ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. (NCT00272064) | Sanofi | 2005-10-01 |
| Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes (NCT00264901) | Novo Nordisk A/S | 2005-10-01 |
| In-patient Study in Patients With Type 2 Diabetes Mellitus (NCT00259896) | GlaxoSmithKline | 2005-10-01 |
| C-Reactive Protein (CRP) in Obese Diabetic Women (NCT00262548) | AstraZeneca | 2005-10-01 |
| An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus (NCT00135330) | AstraZeneca | 2005-10-01 |
| Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus (NCT01709929) | Novo Nordisk A/S | 2005-10-01 |
| Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy (NCT00464776) | Novartis | 2005-10-01 |
| Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes (NCT00237237) | Novartis | 2005-10-01 |
| Study In People With Type 2 Diabetes (NCT00196989) | GlaxoSmithKline | 2005-09-01 |
| Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients (NCT01055093) | German Diabetes Center | 2005-09-01 |
| Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes (NCT00274274) | Novo Nordisk A/S | 2005-09-01 |
| Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs (NCT00491725) | Novo Nordisk A/S | 2005-09-01 |
| Diabetes Telemedicine Consultation: A Systems Improvement Intervention (NCT00119041) | US Department of Veterans Affairs | 2005-09-01 |
| Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema (NCT00417716) | Asociación para Evitar la Ceguera en México | 2005-09-01 |